These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23585829)

  • 1. Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropism.
    Koski A; Karli E; Kipar A; Escutenaire S; Kanerva A; Hemminki A
    PLoS One; 2013; 8(4):e60032. PubMed ID: 23585829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX.
    Stepanenko AA; Chekhonin VP
    Virus Res; 2018 Sep; 257():40-51. PubMed ID: 30125593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting.
    Bayo-Puxan N; Cascallo M; Gros A; Huch M; Fillat C; Alemany R
    J Gen Virol; 2006 Sep; 87(Pt 9):2487-2495. PubMed ID: 16894186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In Vivo.
    Zaiss AK; Foley EM; Lawrence R; Schneider LS; Hoveida H; Secrest P; Catapang AB; Yamaguchi Y; Alemany R; Shayakhmetov DM; Esko JD; Herschman HR
    J Virol; 2016 Jan; 90(1):412-20. PubMed ID: 26491162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement of adenovirus type 5 fiber shaft heparan sulfate proteoglycan-binding domain with RGD for improved tumor infectivity and targeting.
    Bayo-Puxan N; Gimenez-Alejandre M; Lavilla-Alonso S; Gros A; Cascallo M; Hemminki A; Alemany R
    Hum Gene Ther; 2009 Oct; 20(10):1214-21. PubMed ID: 19537946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapy.
    Breidenbach M; Rein DT; Wang M; Nettelbeck DM; Hemminki A; Ulasov I; Rivera AR; Everts M; Alvarez RD; Douglas JT; Curiel DT
    Hum Gene Ther; 2004 May; 15(5):509-18. PubMed ID: 15144580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fiber shaft-chimeric adenovirus vectors lacking the KKTK motif efficiently infect liver cells in vivo.
    Di Paolo NC; Kalyuzhniy O; Shayakhmetov DM
    J Virol; 2007 Nov; 81(22):12249-59. PubMed ID: 17855526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
    Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
    J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta24, for the treatment of advanced breast cancer.
    Ranki T; Kanerva A; Ristimäki A; Hakkarainen T; Särkioja M; Kangasniemi L; Raki M; Laakkonen P; Goodison S; Hemminki A
    Gene Ther; 2007 Jan; 14(1):58-67. PubMed ID: 16900223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic adenoviral gene delivery to orthotopic murine breast tumors with ablation of coagulation factors, thrombocytes and Kupffer cells.
    Koski A; Rajecki M; Guse K; Kanerva A; Ristimäki A; Pesonen S; Escutenaire S; Hemminki A
    J Gene Med; 2009 Nov; 11(11):966-77. PubMed ID: 19670332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats.
    Nicol CG; Graham D; Miller WH; White SJ; Smith TA; Nicklin SA; Stevenson SC; Baker AH
    Mol Ther; 2004 Aug; 10(2):344-54. PubMed ID: 15294181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral serotype 5 vectors pseudotyped with fibers from subgroup D show modified tropism in vitro and in vivo.
    Denby L; Work LM; Graham D; Hsu C; von Seggern DJ; Nicklin SA; Baker AH
    Hum Gene Ther; 2004 Nov; 15(11):1054-64. PubMed ID: 15610606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
    Tsuruta Y; Pereboeva L; Glasgow JN; Rein DT; Kawakami Y; Alvarez RD; Rocconi RP; Siegal GP; Dent P; Fisher PB; Curiel DT
    Clin Cancer Res; 2007 May; 13(9):2777-83. PubMed ID: 17473211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic delivery of a novel liver-detargeted oncolytic adenovirus causes reduced liver toxicity but maintains the antitumor response in a breast cancer bone metastasis model.
    Zhang Z; Krimmel J; Zhang Z; Hu Z; Seth P
    Hum Gene Ther; 2011 Sep; 22(9):1137-42. PubMed ID: 21480822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber.
    Nakamura T; Sato K; Hamada H
    J Virol; 2003 Feb; 77(4):2512-21. PubMed ID: 12551989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity.
    Koizumi N; Kawabata K; Sakurai F; Watanabe Y; Hayakawa T; Mizuguchi H
    Hum Gene Ther; 2006 Mar; 17(3):264-79. PubMed ID: 16544976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy.
    Short JJ; Rivera AA; Wu H; Walter MR; Yamamoto M; Mathis JM; Curiel DT
    Mol Cancer Ther; 2010 Sep; 9(9):2536-44. PubMed ID: 20736345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved systemic antitumor therapy with oncolytic adenoviruses by replacing the fiber shaft HSG-binding domain with RGD.
    Rojas JJ; Gimenez-Alejandre M; Gil-Hoyos R; Cascallo M; Alemany R
    Gene Ther; 2012 Apr; 19(4):453-7. PubMed ID: 21776023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of murine and human factor X on adenovirus transduction via cell-surface heparan sulfate.
    Zaiss AK; Lawrence R; Elashoff D; Esko JD; Herschman HR
    J Biol Chem; 2011 Jul; 286(28):24535-43. PubMed ID: 21596747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotype chimeric and fiber-mutated adenovirus Ad5/19p-HIT for targeting renal cancer and untargeting the liver.
    Diaconu I; Denby L; Pesonen S; Cerullo V; Bauerschmitz GJ; Guse K; Rajecki M; Dias JD; Taari K; Kanerva A; Baker AH; Hemminki A
    Hum Gene Ther; 2009 Jun; 20(6):611-20. PubMed ID: 19239383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.